Artia Global Partners LP 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Artia Global Partners LP disclosed 48 US equity positions worth $443.5m in its Q1 2026 13F filing. The largest position was INSM at 23.2% of the reported book, followed by ABVX and LLY.
What did Artia Global Partners LP own in Q1 2026? Top 48 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 23.2% | $102.8m | 628,712 | – | |
| 2 | ABVX ABIVAX SA | Healthcare | 15.1% | $66.9m | 600,747 | – | |
| 3 | LLY ELI LILLY & CO | Healthcare | 7.9% | $35.2m | 38,220 | – | |
| 4 | TRVI TREVI THERAPEUTICS INC | Healthcare | 5.4% | $24.0m | 2,013,602 | – | |
| 5 | ARGX ARGENX SE | Healthcare | 4.9% | $21.7m | 29,739 | – | |
| 6 | AZN ASTRAZENECA PLC | Healthcare | 4.2% | $18.8m | 95,376 | – | |
| 7 | NEWAMSTERDAM PHARMA COMPANY | 3.6% | $16.1m | 503,936 | – | ||
| 8 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 3.1% | $13.7m | 162,990 | – | |
| 9 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.7% | $12.2m | 124,990 | – | |
| 10 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 2.4% | $10.8m | 144,376 | – | |
| 11 | EYPT EYEPOINT INC | Healthcare | 2.2% | $9.9m | 767,098 | – | |
| 12 | DGX QUEST DIAGNOSTICS INC | Healthcare | 1.8% | $8.0m | 40,817 | – | |
| 13 | ALMS ALUMIS INC | Healthcare | 1.6% | $7.2m | 325,046 | – | |
| 14 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.3% | $5.9m | 180,731 | – | |
| 15 | MRK MERCK & CO INC | Healthcare | 1.3% | $5.6m | 46,700 | – | |
| 16 | 430 TERNS PHARMACEUTICALS INC | 1.2% | $5.5m | 104,800 | – | ||
| 17 | JNJ JOHNSON & JOHNSON | Healthcare | 1.2% | $5.5m | 22,600 | – | |
| 18 | SION SIONNA THERAPEUTICS INC | Healthcare | 1.1% | $4.8m | 119,741 | – | |
| 19 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 1.1% | $4.7m | 96,285 | – | |
| 20 | RAPP RAPPORT THERAPEUTICS INC | 1.0% | $4.3m | 138,508 | – | ||
| 21 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.9% | $4.1m | 17,740 | – | |
| 22 | BLTE BELITE BIO INC | Healthcare | 0.9% | $4.0m | 24,989 | – | |
| 23 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.9% | $3.8m | 65,000 | – | |
| 24 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.8% | $3.7m | 137,800 | – | |
| 25 | ROIV ROIVANT SCIENCES LTD | Healthcare | 0.8% | $3.6m | 129,800 | – | |
| 26 | PALI PALISADE BIO INC | Healthcare | 0.8% | $3.5m | 1,992,367 | – | |
| 27 | BIIB BIOGEN INC | Healthcare | 0.8% | $3.4m | 18,437 | – | |
| 28 | PROK PROKIDNEY CORP | 0.7% | $3.2m | 1,806,939 | – | ||
| 29 | ABBV ABBVIE INC | Healthcare | 0.7% | $3.2m | 14,500 | – | |
| 30 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 0.7% | $3.0m | 5,000 | – | |
| 31 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 0.6% | $2.8m | 38,407 | – | |
| 32 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.5% | $2.4m | 22,931 | – | |
| 33 | SLNOEUR SOLENO THERAPEUTICS INC | 0.5% | $2.3m | 68,490 | – | ||
| 34 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 0.5% | $2.3m | 53,800 | – | |
| 35 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.5% | $2.1m | 70,700 | – | |
| 36 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 0.5% | $2.1m | 65,500 | – | |
| 37 | CELC CELCUITY INC | Healthcare | 0.4% | $1.8m | 15,576 | – | |
| 38 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.3% | $1.5m | 20,400 | – | |
| 39 | KINIKSA PHARMACEUTICALS INTL | 0.3% | $1.4m | 29,200 | – | ||
| 40 | CYTK CYTOKINETICS INC | Healthcare | 0.2% | $1.1m | 16,300 | – | |
| 41 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.2% | $819.3k | 20,900 | – | |
| 42 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.2% | $805.5k | 2,500 | – | |
| 43 | TENX TENAX THERAPEUTICS INC | 0.2% | $672.9k | 42,080 | – | ||
| 44 | KOD KODIAK SCIENCES INC | Healthcare | 0.1% | $648.8k | 17,019 | – | |
| 45 | NUVALENT INC | 0.1% | $502.0k | 4,900 | – | ||
| 46 | APGE APOGEE THERAPEUTICS INC | Healthcare | 0.1% | $495.4k | 5,886 | – | |
| 47 | AVTX AVALO THERAPEUTICS INC | Healthcare | 0.1% | $432.5k | 28,970 | – | |
| 48 | PEPG PEPGEN INC | Healthcare | 0.1% | $363.4k | 205,324 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.